Satsuma Pharmaceuticals
IPOSatsuma Pharmaceuticals is a biotech company. It has raised $62.0M across 1 round, most recently a $62.0M Series B in April 2019.
- Website
- satsumarx.com
- Total Funding
- $62.0M
- Last Round
- $62.0M Series BApr 2019
- Rounds
- 1
- Type
- Public
- Ticker
- STSA · NASDAQ
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 6 investors for this company. The full record is or through the API.
About
It has raised $62.0M in total across 1 round, most recently a $62.0M Series B round in Apr 2019. Investors include RA Capital Management, CAM Capital and Eventide Asset Management.
Tech & App Stack
3 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Apr 2019
Investors
Similar Companies

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/satsuma-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/satsuma-pharmaceuticals" alt="Satsuma Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>
